4//SEC Filing
McCleary Joel 4
Accession 0001104659-09-046098
CIK 0001326190other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 9:01 PM ET
Size
11.0 KB
Accession
0001104659-09-046098
Insider Transaction Report
Form 4
McCleary Joel
Director
Transactions
- Award
10% Unsecured Convertible Note
2009-07-28→ 16,619 totalExercise: $2.54From: 2009-07-28Exp: 2011-07-28→ Common Stock (16,619 underlying) - Award
Common Stock Warrant
2009-07-28+5,633→ 5,633 totalExercise: $2.50From: 2010-01-28Exp: 2015-01-28→ Common Stock (5,633 underlying) - Other
8% Unsecured Convertible Note
2009-07-28→ 0 totalExercise: $10.00Exp: 2009-08-03→ Common Stock (2,673 underlying)
Footnotes (3)
- [F1]Immediately convertible into shares of Common Stock of the Issuer at the rate of $10.00 per share.
- [F2]This Note was received in the Merger of PAI Acquisition Corp., a wholly-owned subsidiary of HealthCare Acquisition Corp. (now known as PharmAthene, Inc.) into PharmAthene, Inc.
- [F3]This Note and Warrant was received in an exempt transaction pursuant to a Note and Warrant Purchase Agreement dated as of July 24, 2009, as amended on July 26, 2009 and July 28, 2009, by and among the Issuer and certain investors, pursuant to which the 8% Senior Unsecured Convertible Note (the "Original Note") reported above was exchanged and $11,195.75 was paid for a new Note in the principal amount of $42,242.03 (the "New Note") and the Warrant reported herein. The terms of the New Note include (i) an increase in the interest rate to 10% per annum; (ii) a reduction in the conversion price of the Original Note from $10.00 per share to $2.541667 per share; and (iii) the issuance of a Warrant to purchase an additional 5,633 shares of Common Stock of the Issuer at a purchase price of $2.50 per share.
Documents
Issuer
PHARMATHENE, INC
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001409933
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 9:01 PM ET
- Size
- 11.0 KB